INEBILIZUMAB
UNII 74T7185BMM

Substance Identification & Data

This profile provides standardized clinical and technical data for Inebilizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 74T7185BMM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1299440-37-1 and the RxNorm Concept ID (RxCUI) 2373951. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

74T7185BMM

CAS Registry Number

1299440-37-1

RxNorm Concept ID

2373951

Detailed Substance Profile

Preferred Name

INEBILIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

74T7185BMM

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C88283

National Cancer Institute reference terminology for clinical and research data.

INN ID

9985

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-114

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inebilizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INEBILIZUMAB

INEBILIZUMAB-CDON

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER

INEBILIZUMAB [INN]

INEBILIZUMAB [JAN]

INEBILIZUMAB [MI]

INEBILIZUMAB [USAN]

INEBILIZUMAB [WHO-DD]

INEBILIZUMAB CDON [WHO-DD]